Literature DB >> 15679481

Hepatitis C virus infection.

B J Thomson1, R G Finch.   

Abstract

Hepatitis C virus (HCV) infection is a major public health problem. Up to 3% of the world's population is infected with HCV, and at least 200 000 adults in the UK carry the virus. Of those exposed to HCV, 80% become chronically infected, and at least 30% of carriers develop chronic liver disease, including cirrhosis and hepatocellular carcinoma. This review provides an overview of selected features of the molecular biology and pathogenesis of HCV infection, and thereafter discusses in detail the epidemiology of HCV, the hepatic and extra-hepatic diseases caused by the virus, and the current treatment options for both acute and chronic virus infection. The special cases of healthcare workers, prison inmates and individuals coinfected with human immunodeficiency virus and HCV are considered in detail.

Entities:  

Mesh:

Year:  2005        PMID: 15679481     DOI: 10.1111/j.1469-0691.2004.01061.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  27 in total

1.  Serological assay and genotyping of hepatitis C virus in infected patients in zanjan province.

Authors:  Abdolreza Esmaeilzadeh; Maryam Erfanmanesh; Sousan Ghasemi; Farzaneh Mohammadi
Journal:  Hepat Mon       Date:  2014-09-27       Impact factor: 0.660

2.  Advancing the high throughput identification of liver fibrosis protein signatures using multiplexed ion mobility spectrometry.

Authors:  Erin Shammel Baker; Kristin E Burnum-Johnson; Jon M Jacobs; Deborah L Diamond; Roslyn N Brown; Yehia M Ibrahim; Daniel J Orton; Paul D Piehowski; David E Purdy; Ronald J Moore; William F Danielson; Matthew E Monroe; Kevin L Crowell; Gordon W Slysz; Marina A Gritsenko; John D Sandoval; Brian L Lamarche; Melissa M Matzke; Bobbie-Jo M Webb-Robertson; Brenna C Simons; Brian J McMahon; Renuka Bhattacharya; James D Perkins; Robert L Carithers; Susan Strom; Steven G Self; Michael G Katze; Gordon A Anderson; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2014-01-08       Impact factor: 5.911

3.  Class III phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of hepatitis C virus replication.

Authors:  Jason Borawski; Philip Troke; Xiaoling Puyang; Veronica Gibaja; Shanchaun Zhao; Craig Mickanin; Juliet Leighton-Davies; Christopher J Wilson; Vic Myer; Ivan Cornellataracido; Jeremy Baryza; John Tallarico; Gerard Joberty; Marcus Bantscheff; Markus Schirle; Tewis Bouwmeester; Joanna E Mathy; Kai Lin; Teresa Compton; Mark Labow; Brigitte Wiedmann; L Alex Gaither
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

4.  Evidence for a dominant major gene conferring predisposition to hepatitis C virus infection in endemic conditions.

Authors:  Cédric Laouénan; Sabine Plancoulaine; Mostafa Kamal Mohamed; Naglaa Arafa; Iman Bakr; Mohamed Abdel-Hamid; Claire Rekacewicz; Dorothée Obach; Arnaud Fontanet; Laurent Abel
Journal:  Hum Genet       Date:  2009-07-23       Impact factor: 4.132

5.  A method for in vitro assembly of hepatitis C virus core protein and for screening of inhibitors.

Authors:  Rémi Fromentin; Nathalie Majeau; Marie-Eve Laliberté Gagné; Annie Boivin; Jean-Baptiste Duvignaud; Denis Leclerc
Journal:  Anal Biochem       Date:  2007-04-02       Impact factor: 3.365

6.  Strong HCV NS3- and NS4A-specific cellular immune responses induced in mice and Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.

Authors:  Krystle A Lang; Jian Yan; Ruxandra Draghia-Akli; Amir Khan; David B Weiner
Journal:  Vaccine       Date:  2008-08-08       Impact factor: 3.641

Review 7.  Using high-throughput genomics to study hepatitis C: what determines the outcome of infection?

Authors:  Kathie-Anne Walters; Michael G Katze
Journal:  Antiviral Res       Date:  2009-01-07       Impact factor: 5.970

8.  Chapter 20 Effects of hepatitis C core protein on mitochondrial electron transport and production of reactive oxygen species.

Authors:  Roosevelt V Campbell; Yuanzheng Yang; Ting Wang; Aparna Rachamallu; Yanchun Li; Stanley J Watowich; Steven A Weinman
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

Review 9.  Cognitive dysfunction in chronic hepatitis C: a review.

Authors:  William Perry; Robin C Hilsabeck; Tarek I Hassanein
Journal:  Dig Dis Sci       Date:  2007-08-17       Impact factor: 3.199

10.  Experiences of Oxford House Residents Living with the Hepatitis C Virus.

Authors:  Richard Contreras; Leonard A Jason
Journal:  Front Psychol Behav Sci       Date:  2013-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.